Posted On: 01/22/2015 4:36:20 PM
Post# of 30015
![Avatar](https://investorshangout.com/images/ProfileImages/1136073171_12849_biology-cells-microscopic-neurons-128x128.jpg)
It makes me wonder about amyvid and the rejection they had from the Centers for Medicare & Medicaid Services for reimbursal last year. Are they the ones that are after Lympro since it will be cheaper and they believe it has a better chance for approval from CMS? the addition of Paul T and the connections to Lilly are interesting to say the least. With blood diagnostics popping up more and more I would think Lilly would want to jump on that asap seeing that amyvid has had some issues for reimbursement and it is about to become obsolete from a pricing standpoint.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)